secwatch.observer — SEC 8-K summary
======================================

Issuer:     MUSTANG BIO, INC. (MBIO)
CIK:        0001680048
Form:       8-K
Filed at:   2026-04-17T23:59:59+00:00
Accession:  0001104659-26-044890
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Mustang Bio receives Nasdaq deficiency notice for bid price below $1.00
-----------------------------------------------------------------------

- Received Nasdaq notice on April 15, 2026 for non-compliance with minimum bid price rule after 30 consecutive business days below $1.00.
- Has 180-calendar day grace period until October 12, 2026 to regain compliance by closing at $1.00+ for 10 consecutive business days.
- May qualify for second 180-day period if meets Nasdaq continued listing criteria and provides written notice of intent to cure.
- Could face delisting if unable to regain compliance; no decision yet on specific actions to remedy deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680048/000110465926044890/0001104659-26-044890-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680048/000110465926044890/tm2612037d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-044890

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer